And mutations in the B2M leading to decreased or absent B2M expression in CNS lymphoma might be a crucial factor, which, in turn, promoted tumor cells to evade immune surveillance (Jordanova et al. 2003). Here, B2M is linked to primary central nervous system lymphoma.